TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer
NCT00940069
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Non-small-cell Lung Cancer
Adenocarcinoma
Interventions
DRUG:
pemetrexed
Sponsor
Hunan Province Tumor Hospital